EFFECTS OF BLOOD MEDIUM SUPPLEMENTS ON ACTIVITIES OF NEWER CEPHALOSPORINS TESTED AGAINST ENTEROCOCCI

被引：6

作者：

BUSCHELMAN, BJ ^{[1
]}

JONES, RN ^{[1
]}

BALE, MJ ^{[1
]}

机构：

[1] UNIV IOWA,COLL MED,DIV MED MICROBIOL,IOWA CITY,IA 52242

来源：

JOURNAL OF CLINICAL MICROBIOLOGY | 1994年 / 32卷 / 02期

关键词：

D O I：

10.1128/JCM.32.2.565-567.1994

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

This comparative study determined the effect of blood on the antienterococcal activities of the newer cephalosporins. Standardized disk diffusion susceptibility tests were performed with 57 strains of enterococci (30 Enterococcus faecalis strains) on Mueller-Hinton agar with and without 5% sheep blood supplementation. Twelve cephalosporins representing five different structural groups (based on the 7-alpha position substitution) were tested. The greatest frequency of activity enhancement by blood was observed with cefdaloxime and cefdinir (7-alpha hydroxyimino group) against E. faecalis. Cephalosporins with a 7-alpha methoxyimino group (cefpodoxime, cefepime, and cefpirome) had marked increases in zone diameters (3 to >9 mm) when tested with the blood supplement. Cephems with 7-alpha amino or carboxy substitutions did not demonstrate any enhanced activity. Awareness of this phenomenon is important for the interpretation and accuracy of cephalosporin susceptibility testing.

引用

页码：565 / 567

页数：3

共 15 条

[1] EFFECT OF BLOOD PRODUCT MEDIUM SUPPLEMENTS ON THE ACTIVITY OF CEFOTAXIME AND OTHER CEPHALOSPORINS AGAINST ENTEROCOCCUS-FAECALIS [J].

ELIOPOULOS, GM ;

REISZNER, E ;

WILLEY, S ;

NOVICK, WJ ;

MOELLERING, RC .

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1989, 12 (02) :149-156

[2] EVALUATION OF THE INVITRO ACTIVITY OF BMY-28142, A NEW BROAD-SPECTRUM CEPHALOSPORIN [J].

FUCHS, PC ;

JONES, RN ;

BARRY, AL ;

THORNSBERRY, C .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1985, 27 (05) :679-682

[3]

Jones R. N., 1988, Antimicrobic Newsletter, V5, P1, DOI 10.1016/0738-1751(88)90015-9

[4] BMY-28100, A NEW ORAL CEPHALOSPORIN - ANTIMICROBIAL ACTIVITY AGAINST NEARLY 7,000 RECENT CLINICAL ISOLATES, COMPARATIVE POTENCY WITH OTHER ORAL-AGENTS, AND ACTIVITY AGAINST BETA-LACTAMASE PRODUCING ISOLATES [J].

JONES, RN ;

BARRY, AL .

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1988, 9 (01) :11-26

[5] DISK DIFFUSION TESTING, QUALITY-CONTROL GUIDELINES, AND ANTIMICROBIAL SPECTRUM OF HR810, A 4TH-GENERATION CEPHALOSPORIN, IN CLINICAL MICROBIOLOGY LABORATORIES [J].

JONES, RN ;

THORNSBERRY, C ;

BARRY, AL ;

AYERS, L ;

BROWN, S ;

DANIEL, J ;

FUCHS, PC ;

GAVAN, TL ;

GERLACH, EH ;

MATSEN, JM ;

RELLER, LB ;

SOMMERS, HM .

JOURNAL OF CLINICAL MICROBIOLOGY, 1984, 20 (03) :409-412

[6] INTERPRETIVE CRITERIA FOR DISK DIFFUSION TESTS USING 5-MICROGRAM CEFDINIR DISKS WITH RAPIDLY GROWING CLINICAL ISOLATES [J].

JONES, RN ;

ERWIN, ME ;

GOODING, BB .

JOURNAL OF CLINICAL MICROBIOLOGY, 1992, 30 (04) :1022-1023

[7]

MOELLERING R C JR, 1984, Diagnostic Microbiology and Infectious Disease, V2, p85S

[8]

Neu H.C., 1986, REV INFECT DIS S3, V8, P237

[9] COMPARATIVE INVITRO ACTIVITY AND BETA-LACTAMASE STABILITY OF FK482, A NEW ORAL CEPHALOSPORIN [J].

NEU, HC ;

SAHA, G ;

CHIN, NX .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (10) :1795-1800

[10]

SAHM DF, 1983, J CLIN MICROBIOL, V4, P858

← 1 2 →